| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
On Friday, April 11, 2025, Cathie Wood-led Ark Invest executed notable trades, shedding shares in UiPath Inc. (NYSE:PATH), Prime Medicine Inc. (NGM: PRME), and Repare Therapeutics Inc. (NASDAQ:RPTX).
The PATH Trade
Ark Invest’s ARK Innovation ETF (NYSE:ARKK) fund sold 4,256 shares of UiPath Inc. Based on the closing price of $10.87 on the day of the trade, the total value of the transaction amounts to approximately $46,280.32.
UiPath’s stock saw a slight increase of 2.26% on the day.
The PRME Trade
Prime Medicine Inc. was another company that Ark Invest decided to reduce its stake in. The ARKK fund sold 83,510 shares of PRME. With the stock closing at $1.33 on the day of the trade, the value of the sold shares is around $111,068.30.
Interestingly, PRME’s stock experienced a significant surge of 13.68% on the trade day.
See Also: JPMorgan CEO Jamie Dimon Expects S&P 500 Growth Forecast To Be Cut
The RPTX Trade
Ark Invest’s Ark Genomic Revolution ETF (BATS:ARKG) fund offloaded shares of Repare Therapeutics Inc. The fund sold 130,611 shares of RPTX. Given the closing price of $0.9 on the trade day, the total value of the transaction is approximately $117,549.90. The stock’s price remained unchanged on the day of the trade.
These trades come in the wake of Ark Invest’s previous transactions, which featured prominent purchases of Tempus AI Inc and Coinbase Global Inc stocks amid a sharp market selloff triggered by economic uncertainty and a 145% China tariff announcement by the Trump administration.
Read Next:
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock
